Touchstone International Medical Science Co (SHSE:688013) Altman Z2-Score: 8.85 (As of Jul. 28, 2026) — 48% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688013 Touchstone International Medical Science Co Ltd SHSE:688013
83 GF Score
Price ¥22.51
GF Value ¥28.55
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Touchstone International Medical Science Co Altman Z2-Score?

Touchstone International Medical Science Co SHSE:688013 -0.44% 83 Altman Z2-Score is 8.85 as of Jul. 28, 2026, which is 48% below its 10-year median of 17.17. GuruFocus rates SHSE:688013 with a GF Score™ of 83/100 and a GF Value™ of ¥28.55 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 839 Medical Devices & Instruments companies, Touchstone International Medical Science Co ranks better than 80.57% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Touchstone International Medical Science Co has a Altman Z2-Score of 8.85, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Touchstone International Medical Science Co's Altman Z2-Score or its related term are showing as below:

SHSE:688013' s Altman Z2-Score Range Over the Past 10 Years
Min: 8.85   Med: 17.17   Max: 31.38
Current: 8.85

During the past 9 years, Touchstone International Medical Science Co's highest Altman Z2-Score was 31.38. The lowest was 8.85. And the median was 17.17.


Touchstone International Medical Science Co  (SHSE:688013) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Touchstone International Medical Science Co Altman Z2-Score Related Terms


Touchstone International Medical Science Co Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Touchstone International Medical Science Co's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Touchstone International Medical Science Co Altman Z2-Score Chart

Touchstone International Medical Science Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only 22.61 20.78 16.36 16.12 9.60

Touchstone International Medical Science Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.44 13.72 13.07 9.60 8.85

SHSE:688013 vs ISRG, BDX, MDLN: Altman Z2-Score Comparison

For the Medical Instruments & Supplies subindustry, Touchstone International Medical Science Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touchstone International Medical Science Co Altman Z2-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Touchstone International Medical Science Co's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Touchstone International Medical Science Co's Altman Z2-Score falls into.


SHSE:688013
83GF Score
Touchstone International Medical Science Co Ltd SHSE:688013
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Touchstone International Medical Science Co Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Touchstone International Medical Science Co's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.3798+3.26*0.1028+6.72*0.1309+1.05*4.897
=8.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was ¥694.4 Mil.
Total Current Assets was ¥367.6 Mil.
Total Current Liabilities was ¥103.9 Mil.
Retained Earnings was ¥71.4 Mil.
Pre-Tax Income was 9.612 + 14.81 + 27.186 + 38.612 = ¥90.2 Mil.
Interest Expense was -0.227 + -0.228 + -0.113 + -0.097 = ¥-0.7 Mil.
Total Liabilities was ¥117.8 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(367.589 - 103.876)/694.384
=0.3798

X2=Retained Earnings/Total Assets
=71.353/694.384
=0.1028

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(90.22 - -0.665)/694.384
=0.1309

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(576.631 - 0)/117.753
=4.897

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Touchstone International Medical Science Co has a Altman Z2-Score of 8.85 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 8.85 mean?
Touchstone International Medical Science Co (SHSE:688013) has a Altman Z2-Score of 8.85 as of Jul. 28, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Touchstone International Medical Science Co and its competitors. This is 48% below median its historical median of 17.17. Over the past decade, Touchstone International Medical Science Co's Altman Z2-Score has ranged from 8.85 to 31.38. According to the industry distribution chart, Touchstone International Medical Science Co ranks #163 out of 839 companies in the Medical Devices & Instruments industry, placing it in the top 19.4%.
Is Touchstone International Medical Science Co's Altman Z2-Score too high?
Touchstone International Medical Science Co's current Altman Z2-Score of 8.85 is 48% below median its 10-year median of 17.17. Over the past 10 years, this metric has ranged from a low of 8.85 to a high of 31.38. The Medical Devices & Instruments industry median Altman Z2-Score is 3.46. Touchstone International Medical Science Co's value of 8.85 is 155.8% above this industry median. Based on the distribution chart, Touchstone International Medical Science Co ranks #163 out of 839 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Touchstone International Medical Science Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Touchstone International Medical Science Co's Altman Z2-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Touchstone International Medical Science Co ranks #163 out of 839 companies for Altman Z2-Score. This places Touchstone International Medical Science Co in the top 19% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 3.46. Touchstone International Medical Science Co's value of 8.85 is 155.8% above this benchmark. Historically, Touchstone International Medical Science Co's own Altman Z2-Score has ranged from 8.85 to 31.38 over the past decade. While the company's 10-year median is 17.17 vs. the industry median of 3.46, Touchstone International Medical Science Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Medical Devices & Instruments company?
The median Altman Z2-Score among Medical Devices & Instruments companies is 3.46, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touchstone International Medical Science Co's current Altman Z2-Score of 8.85 is 155.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Touchstone International Medical Science Co and its competitors. For the Medical Devices & Instruments industry, the median Altman Z2-Score is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touchstone International Medical Science Co's current Altman Z2-Score is 8.85, which is 48% below median its own 10-year median of 17.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touchstone International Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Touchstone International Medical Science Co (SHSE:688013) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.55, compared to a current price of ¥22.51 — trading 21.2% below its estimated fair value. The current Altman Z2-Score is 8.85, which is 48% below median its 10-year median of 17.17 and 155.8% above the Medical Devices & Instruments industry median of 3.46. Touchstone International Medical Science Co's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Touchstone International Medical Science Co (SHSE:688013), the current Altman Z2-Score is 8.85 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Touchstone International Medical Science Co (SHSE:688013) Overvalued in 2026?

Based on GuruFocus' analysis, Touchstone International Medical Science Co stock appears to be undervalued. The current stock price of ¥22.51 is trading 21.2% below its estimated GF Value™ of ¥28.55. GuruFocus considers Touchstone International Medical Science Co to be Modestly Undervalued.

Key valuation signals for SHSE:688013:

  • Altman Z2-Score: 8.85 (48% below median its 10-year median of 17.17)
  • GF Value™: ¥28.55 vs. price of ¥22.51 (21.2% below fair value)
  • GF Score™: 83/100 with 2 warning signs
  • Industry Position: 155.8% above the Medical Devices & Instruments median (#163 of 839)

No single metric tells the full story. See the SHSE:688013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Touchstone International Medical Science Co Business Description

Address 278 Dongping Street, Suzhou Industrial Park, Suzhou, CHN, 215123
Touchstone International Medical Science Co Ltd is specialized in the development of surgical staplers that enhance clinical performance, minimise risk and improve patient outcomes. The company's products include Auto Purse String Clamp for Single Use (APS); Intraluminal Stapler for Single Use (CSC&ECSC); Endoscopic Linear Cutter and Single Use Loading Unit (ELC&ELCC); Intraluminal Stapler for Single Use (KOL); Linear Cutter and Reloads (LC&LCC); Linear Stapler and Reloads (LS&LSC); PPH Stapler and Purse Sets for Single Use (PPH); Tissue - Selecting Therapy Stapler (TST33); Tissue - Selecting Therapy Stapler (TST36); and Tissue - Selecting Therapy Stapler (Proctology Examination Kit).
83GF Score

Get the complete analysis for SHSE:688013

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥22.51
Price
¥28.55
GF Value